There is currently no cure for cystic fibrosis. Treatment for cystic fibrosis is focused on easing symptoms, slowing the progression of the disease, and preventing and treating complications.

Types of Treatments

Treatments for cystic fibrosis include:

  • Airway clearance
  • Medications
  • Surgery
  • Long-term pulmonary rehabilitation
  • Other therapies

Airway clearance – Patients with cystic fibrosis are taught airway clearance techniques that are used several times a day.

Airway clearance techniques used for cystic fibrosis include:

  • Chest physical therapy
  • Cupping with hands on the front and back of chest
  • Breathing and coughing techniques
  • The use of machines, such as a vibrating vest, that pulse air into the lungs

Medications – Medications used to treat cystic fibrosis may include:

  • Antibiotics
  • Anti-inflammatory drugs
  • Mucus-thinning drugs
  • Bronchodilators (to keep airways open)
  • Oral pancreatic enzymes (to improve nutrient absorption)
  • Stool softeners
  • Acid-reduction medications

Antibiotics – Inhaled antibiotics, such as tobramycin and aztreonam, may be used to treat lung infections in patients with cystic fibrosis.

Anti-inflammatory drugs, such as ibuprofen, are used to lessen swelling associated with cystic fibrosis

Mucus-thinning medication – The drug, dornase alfa, and hypertonic saline, may be used to thin the thick mucus associated with cystic fibrosis.

Bronchodilators – Inhaled bronchodilators, such as albuterol, are used to open the airways in patients with cystic fibrosis.

Oral pancreatic enzymes – Oral pancreatic enzymes, such as lipase, protease, and amylase, are taken before meals by patients with cystic fibrosis to help break down food.

Stool softeners – Stool softeners, such as polyethylene glycol, are used to prevent intestinal obstructions in patients with cystic fibrosis.

Gene-targeted therapy – Patients with cystic fibrosis who have certain gene mutations may be given gene-target therapy to improve lung function, weight, and to reduce the amount of sodium in sweat.

Gene-targeted therapy for the treatment of cystic fibrosis may include:

  • Elexacaftor
  • Ivacaftor
  • Tezacaftor
  • Combination of tezacaftor and invacaftor
  • Combination of lumacaftor and ivacaftor

Acid-reducing drugs – Acid-reducing drugs for the treatment of cystic fibrosis may include the proton pump inhibitors:

  • Ecomeprazole
  • Lansoprazole
  • Omeprazole

Surgery – Some patients with cystic fibrosis may need surgery to remove nasal polyps, to treat chronic sinusitis, or to repair an intestinal obstruction.

In some selected patients with severe lung damage due to cystic fibrosis, lung transplantation may be an option.

For patients with cystic-fibrosis liver disease, such as scarring of the liver, also called cirrhosis, liver transplantation may be an option. Liver transplantation can be combined with lung or pancreas transplantation.

Other therapies – Additional therapies for cystic fibrosis may include:

  • Oxygen therapy to prevent pulmonary hypertension, which is high blood pressure in the main lung artery
  • Noninvasive ventilation, also called CPAP, which uses a machine and mask to assist breathing while sleeping
  • Placement of a feeding tube to counteract or prevent malnutrition
  • Vitamin therapy with vitamins A, D, E, and K
  • Diet therapy

Long-term pulmonary rehabilitation – Pulmonary rehabilitation for cystic fibrosis includes:

  • Exercise
  • Nutritional counseling
  • Supportive counseling
  • Cystic fibrosis education

New, Experimental Treatments

The existing antifungal drug, amphotericin, has recently been shown to help improve lung function in patients with cystic fibrosis. Amphotericin can also help to fight off the chronic bacterial infections that are a hallmark of the disease.

Long-Term Follow Up

Long-term follow-up is necessary for patients with cystic fibrosis to prevent and treat infections and complications and monitor treatment effectiveness.

Sources

This content was written by the MediFind Medical Team. Last updated: 6/9/2022

Cystic Fibrosis Approved Drugs

These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Cystic Fibrosis.

Found 5 Approved Drugs for Cystic Fibrosis

Tobramycin

Brand Names
TOBI Podhaler, TOBI, Bethkis, TobraDex, Tobrex

Tobramycin

Brand Names
TOBI Podhaler, TOBI, Bethkis, TobraDex, Tobrex
TOBRADEX ® ST ophthalmic suspension is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists. Ocular steroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe where the inherent risk of steroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. They are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation or thermal burns, or penetration of foreign bodies. The use of a combination drug with an anti-infective component is indicated where the risk of superficial ocular infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye. The particular anti-infective drug in this product is active against the following common bacterial eye pathogens: Staphylococci, including S. aureus and S. epidermidis (coagulase-positive and coagulase-negative), including penicillin-resistant isolates. Streptococci, including some Group A and other beta-hemolytic species, some nonhemolytic species, and some Streptococcus pneumoniae, Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, Enterobacter aerogenes, Proteus mirabilis, Morganella morganii, most Proteus vulgaris isolates, Haemophilus influenzae, H. aegyptius, Moraxella lacunata, Acinetobacter calcoaceticus and some Neisseria species. TOBRADEX ® ST is a topical antibiotic and corticosteroid combination for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists.

Ivacaftor

Brand Names
Trikafta, Kalydeco, Symdeko, Orkambi

Ivacaftor

Brand Names
Trikafta, Kalydeco, Symdeko, Orkambi
TRIKAFTA is indicated for the treatment of cystic fibrosis (CF) in patients aged 2 years and older who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator ( CFTR ) gene or a mutation in the CFTR gene that is responsive based on clinical and/or in vitro data [see Clinical Pharmacology (1.

Azithromycin

Brand Names
Azasite, Zithromax

Azithromycin

Brand Names
Azasite, Zithromax
Azithromycin for oral suspension USP is a macrolide antibacterial drug indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below. Recommended dosages and durations of therapy in adult and pediatric patient populations vary in these indications.

Pulmozyme

Generic Name
Dornase

Pulmozyme

Generic Name
Dornase
PULMOZYME ® is indicated, in conjunction with standard therapies, for the management of pediatric and adult patients with cystic fibrosis (CF) to improve pulmonary function. In CF patients with an FVC ≥ 40% of predicted, daily administration of PULMOZYME has also been shown to reduce the risk of respiratory tract infections requiring parenteral antibiotics. PULMOZYME is a recombinant DNase enzyme indicated in conjunction with standard therapies for the management of cystic fibrosis (CF) patients to improve pulmonary function. ( 1 )

Alyftrek

Generic Name
Tezacaftor

Alyftrek

Generic Name
Tezacaftor
ALYFTREK is indicated for the treatment of cystic fibrosis (CF) in patients 6 years of age and older who have at least one F508del mutation or another responsive mutation in the cystic fibrosis transmembrane conductance regulator ( CFTR ) gene [see Clinical Pharmacology (1.
Showing 1-5 of 5
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances